Rchr
J-GLOBAL ID：202001011630752548
Update date: Apr. 15, 2024
Matsuoka Katsuyoshi
マツオカ カツヨシ | Matsuoka Katsuyoshi
Affiliation and department：
Job title：
Professor
Research theme for competitive and other funds (6)：
Papers (20)：
-
Matsuoka K, Fujii T, Okamoto R, Yamada A, Kunisaki R, Matsuura M, Watanabe K, Shiga H, Takatsu N, Bamba S, et al. Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD). Journal of gastroenterology. 2022. 57. 867-878
-
Matsuoka K, Hisamatsu T, Kim HJ, Ye BD, Arai S, Hoshi M, Yuasa H, Tabira J, Toyoizumi S, Shi N, et al. Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open. Journal of gastroenterology and hepatology. 2022. 37. 1884-1892
-
Okabayashi S, Yamazaki H, Yamamoto R, Anan K, Matsuoka K, Kobayashi T, Shinzaki S, Honzawa Y, Kataoka Y, Tsujimoto Y, et al. Certolizumab pegol for maintenance of medically induced remission in Crohn's disease. The Cochrane database of systematic reviews. 2022. 6. CD013747
-
Matsuoka K, Nagano K, Nagasaki S, Murata Y, Hisamatsu T. Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study. BMJ open. 2022. 12. e060081-1892
-
Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, et al. Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS). Journal of gastroenterology. 2022. 57. 174-184
ｍore...
Work history (1)：
- 2018/04 - 現在 Toho University Faculty of Medicine School of Medicine (Sakura) Professor
Return to Previous Page
